Medical Care
Hodgkin Lymphoma Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 547000
- Pages: 105
- Figures: 178
- Views: 2
The global market for Hodgkin Lymphoma Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hodgkin Lymphoma Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hodgkin Lymphoma Treatment by region & country, by Type, and by Application.
The Hodgkin Lymphoma Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hodgkin Lymphoma Treatment.
Market Segmentation
By Company
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Merck & Co., Inc.
Mirati Therapeutics Inc.
Molecular Templates Inc.
NantKwest, Inc.
Segment by Type:
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others
Segment by Application
Hospital
Clinic
Research Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hodgkin Lymphoma Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hodgkin Lymphoma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hodgkin Lymphoma Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hodgkin Lymphoma Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hodgkin Lymphoma Treatment by region & country, by Type, and by Application.
The Hodgkin Lymphoma Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hodgkin Lymphoma Treatment.
Market Segmentation
By Company
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Merck & Co., Inc.
Mirati Therapeutics Inc.
Molecular Templates Inc.
NantKwest, Inc.
Segment by Type:
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others
Segment by Application
Hospital
Clinic
Research Center
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hodgkin Lymphoma Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hodgkin Lymphoma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hodgkin Lymphoma Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Hodgkin Lymphoma Treatment Product Introduction
1.2 Global Hodgkin Lymphoma Treatment Market Size Forecast
1.3 Hodgkin Lymphoma Treatment Market Trends & Drivers
1.3.1 Hodgkin Lymphoma Treatment Industry Trends
1.3.2 Hodgkin Lymphoma Treatment Market Drivers & Opportunity
1.3.3 Hodgkin Lymphoma Treatment Market Challenges
1.3.4 Hodgkin Lymphoma Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hodgkin Lymphoma Treatment Players Revenue Ranking (2023)
2.2 Global Hodgkin Lymphoma Treatment Revenue by Company (2019-2024)
2.3 Key Companies Hodgkin Lymphoma Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hodgkin Lymphoma Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Hodgkin Lymphoma Treatment
2.6 Hodgkin Lymphoma Treatment Market Competitive Analysis
2.6.1 Hodgkin Lymphoma Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Hodgkin Lymphoma Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Alocrest
3.1.2 ANK Program
3.1.3 Azacitidine
3.1.4 BMS-986016
3.1.5 BPX-501
3.1.6 Others
3.2 Global Hodgkin Lymphoma Treatment Sales Value by Type
3.2.1 Global Hodgkin Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hodgkin Lymphoma Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Hodgkin Lymphoma Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Center
4.2 Global Hodgkin Lymphoma Treatment Sales Value by Application
4.2.1 Global Hodgkin Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hodgkin Lymphoma Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Hodgkin Lymphoma Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Hodgkin Lymphoma Treatment Sales Value by Region
5.1.1 Global Hodgkin Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hodgkin Lymphoma Treatment Sales Value by Region (2019-2024)
5.1.3 Global Hodgkin Lymphoma Treatment Sales Value by Region (2025-2030)
5.1.4 Global Hodgkin Lymphoma Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.2.2 North America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.3.2 Europe Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.5.2 South America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value
6.3 United States
6.3.1 United States Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.3.2 United States Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.4.2 Europe Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.5.2 China Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.6.2 Japan Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.7.2 South Korea Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.9.2 India Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cell Medica Limited
7.1.1 Cell Medica Limited Profile
7.1.2 Cell Medica Limited Main Business
7.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Products, Services and Solutions
7.1.4 Cell Medica Limited Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Cell Medica Limited Recent Developments
7.2 Cellular Biomedicine Group, Inc.
7.2.1 Cellular Biomedicine Group, Inc. Profile
7.2.2 Cellular Biomedicine Group, Inc. Main Business
7.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.2.4 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Cellular Biomedicine Group, Inc. Recent Developments
7.3 Constellation Pharmaceuticals, Inc.
7.3.1 Constellation Pharmaceuticals, Inc. Profile
7.3.2 Constellation Pharmaceuticals, Inc. Main Business
7.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.3.4 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Curis, Inc. Recent Developments
7.4 Curis, Inc.
7.4.1 Curis, Inc. Profile
7.4.2 Curis, Inc. Main Business
7.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.4.4 Curis, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Curis, Inc. Recent Developments
7.5 Faron Pharmaceuticals Oy
7.5.1 Faron Pharmaceuticals Oy Profile
7.5.2 Faron Pharmaceuticals Oy Main Business
7.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Products, Services and Solutions
7.5.4 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Faron Pharmaceuticals Oy Recent Developments
7.6 Fate Therapeutics, Inc.
7.6.1 Fate Therapeutics, Inc. Profile
7.6.2 Fate Therapeutics, Inc. Main Business
7.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.6.4 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Fate Therapeutics, Inc. Recent Developments
7.7 Gamida Cell Ltd.
7.7.1 Gamida Cell Ltd. Profile
7.7.2 Gamida Cell Ltd. Main Business
7.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.7.4 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Gamida Cell Ltd. Recent Developments
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Profile
7.8.2 Gilead Sciences, Inc. Main Business
7.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.8.4 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Gilead Sciences, Inc. Recent Developments
7.9 Incyte Corporation
7.9.1 Incyte Corporation Profile
7.9.2 Incyte Corporation Main Business
7.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Products, Services and Solutions
7.9.4 Incyte Corporation Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Incyte Corporation Recent Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Profile
7.10.2 Merck & Co., Inc. Main Business
7.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.10.4 Merck & Co., Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Merck & Co., Inc. Recent Developments
7.11 Mirati Therapeutics Inc.
7.11.1 Mirati Therapeutics Inc. Profile
7.11.2 Mirati Therapeutics Inc. Main Business
7.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.11.4 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Mirati Therapeutics Inc. Recent Developments
7.12 Molecular Templates Inc.
7.12.1 Molecular Templates Inc. Profile
7.12.2 Molecular Templates Inc. Main Business
7.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.12.4 Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Molecular Templates Inc. Recent Developments
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Profile
7.13.2 NantKwest, Inc. Main Business
7.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.13.4 NantKwest, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 NantKwest, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Hodgkin Lymphoma Treatment Industrial Chain
8.2 Hodgkin Lymphoma Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hodgkin Lymphoma Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Hodgkin Lymphoma Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Hodgkin Lymphoma Treatment Product Introduction
1.2 Global Hodgkin Lymphoma Treatment Market Size Forecast
1.3 Hodgkin Lymphoma Treatment Market Trends & Drivers
1.3.1 Hodgkin Lymphoma Treatment Industry Trends
1.3.2 Hodgkin Lymphoma Treatment Market Drivers & Opportunity
1.3.3 Hodgkin Lymphoma Treatment Market Challenges
1.3.4 Hodgkin Lymphoma Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hodgkin Lymphoma Treatment Players Revenue Ranking (2023)
2.2 Global Hodgkin Lymphoma Treatment Revenue by Company (2019-2024)
2.3 Key Companies Hodgkin Lymphoma Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Hodgkin Lymphoma Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Hodgkin Lymphoma Treatment
2.6 Hodgkin Lymphoma Treatment Market Competitive Analysis
2.6.1 Hodgkin Lymphoma Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Hodgkin Lymphoma Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Alocrest
3.1.2 ANK Program
3.1.3 Azacitidine
3.1.4 BMS-986016
3.1.5 BPX-501
3.1.6 Others
3.2 Global Hodgkin Lymphoma Treatment Sales Value by Type
3.2.1 Global Hodgkin Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hodgkin Lymphoma Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Hodgkin Lymphoma Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Center
4.2 Global Hodgkin Lymphoma Treatment Sales Value by Application
4.2.1 Global Hodgkin Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hodgkin Lymphoma Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Hodgkin Lymphoma Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Hodgkin Lymphoma Treatment Sales Value by Region
5.1.1 Global Hodgkin Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hodgkin Lymphoma Treatment Sales Value by Region (2019-2024)
5.1.3 Global Hodgkin Lymphoma Treatment Sales Value by Region (2025-2030)
5.1.4 Global Hodgkin Lymphoma Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.2.2 North America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.3.2 Europe Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.5.2 South America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Hodgkin Lymphoma Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value
6.3 United States
6.3.1 United States Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.3.2 United States Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.4.2 Europe Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.5.2 China Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.6.2 Japan Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.7.2 South Korea Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hodgkin Lymphoma Treatment Sales Value, 2019-2030
6.9.2 India Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hodgkin Lymphoma Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cell Medica Limited
7.1.1 Cell Medica Limited Profile
7.1.2 Cell Medica Limited Main Business
7.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Products, Services and Solutions
7.1.4 Cell Medica Limited Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Cell Medica Limited Recent Developments
7.2 Cellular Biomedicine Group, Inc.
7.2.1 Cellular Biomedicine Group, Inc. Profile
7.2.2 Cellular Biomedicine Group, Inc. Main Business
7.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.2.4 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Cellular Biomedicine Group, Inc. Recent Developments
7.3 Constellation Pharmaceuticals, Inc.
7.3.1 Constellation Pharmaceuticals, Inc. Profile
7.3.2 Constellation Pharmaceuticals, Inc. Main Business
7.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.3.4 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Curis, Inc. Recent Developments
7.4 Curis, Inc.
7.4.1 Curis, Inc. Profile
7.4.2 Curis, Inc. Main Business
7.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.4.4 Curis, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Curis, Inc. Recent Developments
7.5 Faron Pharmaceuticals Oy
7.5.1 Faron Pharmaceuticals Oy Profile
7.5.2 Faron Pharmaceuticals Oy Main Business
7.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Products, Services and Solutions
7.5.4 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Faron Pharmaceuticals Oy Recent Developments
7.6 Fate Therapeutics, Inc.
7.6.1 Fate Therapeutics, Inc. Profile
7.6.2 Fate Therapeutics, Inc. Main Business
7.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.6.4 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Fate Therapeutics, Inc. Recent Developments
7.7 Gamida Cell Ltd.
7.7.1 Gamida Cell Ltd. Profile
7.7.2 Gamida Cell Ltd. Main Business
7.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.7.4 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Gamida Cell Ltd. Recent Developments
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Profile
7.8.2 Gilead Sciences, Inc. Main Business
7.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.8.4 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Gilead Sciences, Inc. Recent Developments
7.9 Incyte Corporation
7.9.1 Incyte Corporation Profile
7.9.2 Incyte Corporation Main Business
7.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Products, Services and Solutions
7.9.4 Incyte Corporation Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Incyte Corporation Recent Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Profile
7.10.2 Merck & Co., Inc. Main Business
7.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.10.4 Merck & Co., Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Merck & Co., Inc. Recent Developments
7.11 Mirati Therapeutics Inc.
7.11.1 Mirati Therapeutics Inc. Profile
7.11.2 Mirati Therapeutics Inc. Main Business
7.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.11.4 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Mirati Therapeutics Inc. Recent Developments
7.12 Molecular Templates Inc.
7.12.1 Molecular Templates Inc. Profile
7.12.2 Molecular Templates Inc. Main Business
7.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.12.4 Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Molecular Templates Inc. Recent Developments
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Profile
7.13.2 NantKwest, Inc. Main Business
7.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
7.13.4 NantKwest, Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 NantKwest, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Hodgkin Lymphoma Treatment Industrial Chain
8.2 Hodgkin Lymphoma Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hodgkin Lymphoma Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Hodgkin Lymphoma Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hodgkin Lymphoma Treatment Market Trends
Table 2. Hodgkin Lymphoma Treatment Market Drivers & Opportunity
Table 3. Hodgkin Lymphoma Treatment Market Challenges
Table 4. Hodgkin Lymphoma Treatment Market Restraints
Table 5. Global Hodgkin Lymphoma Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hodgkin Lymphoma Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hodgkin Lymphoma Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hodgkin Lymphoma Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Hodgkin Lymphoma Treatment
Table 10. Global Hodgkin Lymphoma Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hodgkin Lymphoma Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hodgkin Lymphoma Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hodgkin Lymphoma Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hodgkin Lymphoma Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hodgkin Lymphoma Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hodgkin Lymphoma Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hodgkin Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hodgkin Lymphoma Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hodgkin Lymphoma Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hodgkin Lymphoma Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Hodgkin Lymphoma Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Cell Medica Limited Basic Information List
Table 32. Cell Medica Limited Description and Business Overview
Table 33. Cell Medica Limited Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Cell Medica Limited (2019-2024)
Table 35. Cell Medica Limited Recent Developments
Table 36. Cellular Biomedicine Group, Inc. Basic Information List
Table 37. Cellular Biomedicine Group, Inc. Description and Business Overview
Table 38. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Cellular Biomedicine Group, Inc. (2019-2024)
Table 40. Cellular Biomedicine Group, Inc. Recent Developments
Table 41. Constellation Pharmaceuticals, Inc. Basic Information List
Table 42. Constellation Pharmaceuticals, Inc. Description and Business Overview
Table 43. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Constellation Pharmaceuticals, Inc. (2019-2024)
Table 45. Constellation Pharmaceuticals, Inc. Recent Developments
Table 46. Curis, Inc. Basic Information List
Table 47. Curis, Inc. Description and Business Overview
Table 48. Curis, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Curis, Inc. (2019-2024)
Table 50. Curis, Inc. Recent Developments
Table 51. Faron Pharmaceuticals Oy Basic Information List
Table 52. Faron Pharmaceuticals Oy Description and Business Overview
Table 53. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Faron Pharmaceuticals Oy (2019-2024)
Table 55. Faron Pharmaceuticals Oy Recent Developments
Table 56. Fate Therapeutics, Inc. Basic Information List
Table 57. Fate Therapeutics, Inc. Description and Business Overview
Table 58. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Fate Therapeutics, Inc. (2019-2024)
Table 60. Fate Therapeutics, Inc. Recent Developments
Table 61. Gamida Cell Ltd. Basic Information List
Table 62. Gamida Cell Ltd. Description and Business Overview
Table 63. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Gamida Cell Ltd. (2019-2024)
Table 65. Gamida Cell Ltd. Recent Developments
Table 66. Gilead Sciences, Inc. Basic Information List
Table 67. Gilead Sciences, Inc. Description and Business Overview
Table 68. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Gilead Sciences, Inc. (2019-2024)
Table 70. Gilead Sciences, Inc. Recent Developments
Table 71. Incyte Corporation Basic Information List
Table 72. Incyte Corporation Description and Business Overview
Table 73. Incyte Corporation Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Incyte Corporation (2019-2024)
Table 75. Incyte Corporation Recent Developments
Table 76. Merck & Co., Inc. Basic Information List
Table 77. Merck & Co., Inc. Description and Business Overview
Table 78. Merck & Co., Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Merck & Co., Inc. (2019-2024)
Table 80. Merck & Co., Inc. Recent Developments
Table 81. Mirati Therapeutics Inc. Basic Information List
Table 82. Mirati Therapeutics Inc. Description and Business Overview
Table 83. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Mirati Therapeutics Inc. (2019-2024)
Table 85. Mirati Therapeutics Inc. Recent Developments
Table 86. Molecular Templates Inc. Basic Information List
Table 87. Molecular Templates Inc. Description and Business Overview
Table 88. Molecular Templates Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Molecular Templates Inc. (2019-2024)
Table 90. Molecular Templates Inc. Recent Developments
Table 91. NantKwest, Inc. Basic Information List
Table 92. NantKwest, Inc. Description and Business Overview
Table 93. NantKwest, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of NantKwest, Inc. (2019-2024)
Table 95. NantKwest, Inc. Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Hodgkin Lymphoma Treatment Downstream Customers
Table 99. Hodgkin Lymphoma Treatment Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hodgkin Lymphoma Treatment Product Picture
Figure 2. Global Hodgkin Lymphoma Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Hodgkin Lymphoma Treatment Report Years Considered
Figure 5. Global Hodgkin Lymphoma Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hodgkin Lymphoma Treatment Revenue in 2023
Figure 7. Hodgkin Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Alocrest Picture
Figure 9. ANK Program Picture
Figure 10. Azacitidine Picture
Figure 11. BMS-986016 Picture
Figure 12. BPX-501 Picture
Figure 13. Others Picture
Figure 14. Global Hodgkin Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Hodgkin Lymphoma Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Research Center
Figure 19. Global Hodgkin Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Hodgkin Lymphoma Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value (%), (2019-2030)
Figure 32. United States Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. China Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. China Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. India Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. India Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Hodgkin Lymphoma Treatment Industrial Chain
Figure 54. Hodgkin Lymphoma Treatment Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Table 1. Hodgkin Lymphoma Treatment Market Trends
Table 2. Hodgkin Lymphoma Treatment Market Drivers & Opportunity
Table 3. Hodgkin Lymphoma Treatment Market Challenges
Table 4. Hodgkin Lymphoma Treatment Market Restraints
Table 5. Global Hodgkin Lymphoma Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hodgkin Lymphoma Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hodgkin Lymphoma Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hodgkin Lymphoma Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Hodgkin Lymphoma Treatment
Table 10. Global Hodgkin Lymphoma Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hodgkin Lymphoma Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hodgkin Lymphoma Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hodgkin Lymphoma Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hodgkin Lymphoma Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hodgkin Lymphoma Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hodgkin Lymphoma Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hodgkin Lymphoma Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hodgkin Lymphoma Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hodgkin Lymphoma Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hodgkin Lymphoma Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hodgkin Lymphoma Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Hodgkin Lymphoma Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Cell Medica Limited Basic Information List
Table 32. Cell Medica Limited Description and Business Overview
Table 33. Cell Medica Limited Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Cell Medica Limited (2019-2024)
Table 35. Cell Medica Limited Recent Developments
Table 36. Cellular Biomedicine Group, Inc. Basic Information List
Table 37. Cellular Biomedicine Group, Inc. Description and Business Overview
Table 38. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Cellular Biomedicine Group, Inc. (2019-2024)
Table 40. Cellular Biomedicine Group, Inc. Recent Developments
Table 41. Constellation Pharmaceuticals, Inc. Basic Information List
Table 42. Constellation Pharmaceuticals, Inc. Description and Business Overview
Table 43. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Constellation Pharmaceuticals, Inc. (2019-2024)
Table 45. Constellation Pharmaceuticals, Inc. Recent Developments
Table 46. Curis, Inc. Basic Information List
Table 47. Curis, Inc. Description and Business Overview
Table 48. Curis, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Curis, Inc. (2019-2024)
Table 50. Curis, Inc. Recent Developments
Table 51. Faron Pharmaceuticals Oy Basic Information List
Table 52. Faron Pharmaceuticals Oy Description and Business Overview
Table 53. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Faron Pharmaceuticals Oy (2019-2024)
Table 55. Faron Pharmaceuticals Oy Recent Developments
Table 56. Fate Therapeutics, Inc. Basic Information List
Table 57. Fate Therapeutics, Inc. Description and Business Overview
Table 58. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Fate Therapeutics, Inc. (2019-2024)
Table 60. Fate Therapeutics, Inc. Recent Developments
Table 61. Gamida Cell Ltd. Basic Information List
Table 62. Gamida Cell Ltd. Description and Business Overview
Table 63. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Gamida Cell Ltd. (2019-2024)
Table 65. Gamida Cell Ltd. Recent Developments
Table 66. Gilead Sciences, Inc. Basic Information List
Table 67. Gilead Sciences, Inc. Description and Business Overview
Table 68. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Gilead Sciences, Inc. (2019-2024)
Table 70. Gilead Sciences, Inc. Recent Developments
Table 71. Incyte Corporation Basic Information List
Table 72. Incyte Corporation Description and Business Overview
Table 73. Incyte Corporation Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Incyte Corporation (2019-2024)
Table 75. Incyte Corporation Recent Developments
Table 76. Merck & Co., Inc. Basic Information List
Table 77. Merck & Co., Inc. Description and Business Overview
Table 78. Merck & Co., Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Merck & Co., Inc. (2019-2024)
Table 80. Merck & Co., Inc. Recent Developments
Table 81. Mirati Therapeutics Inc. Basic Information List
Table 82. Mirati Therapeutics Inc. Description and Business Overview
Table 83. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Mirati Therapeutics Inc. (2019-2024)
Table 85. Mirati Therapeutics Inc. Recent Developments
Table 86. Molecular Templates Inc. Basic Information List
Table 87. Molecular Templates Inc. Description and Business Overview
Table 88. Molecular Templates Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of Molecular Templates Inc. (2019-2024)
Table 90. Molecular Templates Inc. Recent Developments
Table 91. NantKwest, Inc. Basic Information List
Table 92. NantKwest, Inc. Description and Business Overview
Table 93. NantKwest, Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hodgkin Lymphoma Treatment Business of NantKwest, Inc. (2019-2024)
Table 95. NantKwest, Inc. Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Hodgkin Lymphoma Treatment Downstream Customers
Table 99. Hodgkin Lymphoma Treatment Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hodgkin Lymphoma Treatment Product Picture
Figure 2. Global Hodgkin Lymphoma Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Hodgkin Lymphoma Treatment Report Years Considered
Figure 5. Global Hodgkin Lymphoma Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hodgkin Lymphoma Treatment Revenue in 2023
Figure 7. Hodgkin Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Alocrest Picture
Figure 9. ANK Program Picture
Figure 10. Azacitidine Picture
Figure 11. BMS-986016 Picture
Figure 12. BPX-501 Picture
Figure 13. Others Picture
Figure 14. Global Hodgkin Lymphoma Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Hodgkin Lymphoma Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Research Center
Figure 19. Global Hodgkin Lymphoma Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Hodgkin Lymphoma Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Hodgkin Lymphoma Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Hodgkin Lymphoma Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Hodgkin Lymphoma Treatment Sales Value (%), (2019-2030)
Figure 32. United States Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. China Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. China Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. India Hodgkin Lymphoma Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Hodgkin Lymphoma Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. India Hodgkin Lymphoma Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Hodgkin Lymphoma Treatment Industrial Chain
Figure 54. Hodgkin Lymphoma Treatment Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232